Clinical Research
Our Research Mission
We prioritize safety and efficacy in our research and are dedicated to advancing the development of new medications while maintaining high standards of patient care and quick study initiation.
By participating in a research study, patients may gain access to investigational medications that are not currently available outside of the study. Their participation helps contribute to research that may bring forth new treatments and therapies to people with similar conditions.
By participating in a research study, patients may gain access to investigational medications that are not currently available outside of the study. Their participation helps contribute to research that may bring forth new treatments and therapies to people with similar conditions.
Premier Research Facilities
The clinical research facility at Doc1 Health combines cutting-edge technology with expert staff to deliver exceptional healthcare solutions. Below are a few of our facility highlights:
On site IP pharmacy for compounding/blinding services
Laboratory with refrigerated centrifuge
Secondary lab dedicated for PK draws
-20 and -70 degree freezers for PK samples
Dedicated monitoring suite to accommodate up to 4 monitors
Patient safety equipment and crash cart
On site IP pharmacy for compounding/blinding services
Laboratory with refrigerated centrifuge
Secondary lab dedicated for PK draws
-20 and -70 degree freezers for PK samples
Dedicated monitoring suite to accommodate up to 4 monitors
Patient safety equipment and crash cart
Our Clinical Trial Partners
Doc1 Health has forged a formidable strategic partnership with leading clinical trial sponsors, Amgen and Kashiv Biosciences, leveraging their collective expertise to advance groundbreaking medical research and accelerate the development of innovative treatments.
Physicians
Efficiently integrate clinical trials into routine care, enhancing patient access to innovative treatments in and around underserved communities.
Pharma/CRO
Doc1 Health collaborates closely with pharma companies to drive innovation and accelerate the development of life-changing therapies.
